510(k) Report

510(k) · Cleared

Cleared

MT-200

K973751510(k) TraditionalCleared Aug 25, 1998328-day reviewClass II21 CFR 870.1425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Schiller America, Inc. · DQK Computer, Diagnostic, Programmable

Cleared on Aug 25, 1998 as substantially equivalent to K914577 (Precision Health Care Systems, Inc., 1992) after a 328-day review. Its family tree reaches back 1 generation to 1992.

Decided
Aug 25, 1998
Review
328 days
Class
Class II
Product code
DQK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K914577 (1992). No later device cites it as a predicate yet.

K914577 · Rhythmscan Precision 6000 · Precision Health Care Systems, Inc. · 1992199019921994199619982000
  1. Root · 1 generation backK914577 Rhythmscan Precision 6000Precision Health Care Systems, Inc. · 1992
  2. This deviceK973751 MT-200Schiller America, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K914577Rhythmscan Precision 6000Precision Health Care Systems, Inc.1992—
0 (this device)K973751MT-200Schiller America, Inc.1998—
FIG. 1 — Lineage of K973751, 1992–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQK device

  1. #1 K213682 HemoSphere Advanced Monitor, HemoSphere…score 26.7 · 28 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K914577Rhythmscan Precision 6000
Summary page 1
…Diagnostic Proororrwnoble Class 2 A3 legally Marketed Device Legally Marketed Device to which this submitted device Is ocmpc:ed Brentwood Rhythrnscan Pracision CS-6000 (K914577) L A4 Description of Submitted Device , The ECG Holfer evaluation software, MT-200, is an analysis 8 used for the analysis and…
Precision Health Care Systems, Inc.1992—

Also cleared against K914577: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K914577.

How does its category compare?

All DQK devices

DQK Computer, Diagnostic, Programmable: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQK

23so far in 2026, the most since 2007

2007: 132008: 42009: 122010: 92011: 122012: 72013: 132014: 92015: 72016: 152017: 72018: 142019: 152020: 162021: 162022: 192023: 212024: 132025: 222026 (partial year): 23
2007high 23 (2026) · low 4 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQK

95in 2025

2007: 83 days median2008: 70 days median2009: 93 days median2010: 64 days median2011: 69 days median2012: 74 days median2013: 68 days median2014: 90 days median2015: 125 days median2016: 190 days median2017: 146 days median2018: 150 days median2019: 113 days median2020: 123 days median2021: 132 days median2022: 136 days median2023: 133 days median2024: 100 days median2025: 95 days median2026 (partial year): 151 days median
2007high 190 (2016) · low 64 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQK

1in 2025

2007: 42008: 12009: 22010: 32011: 22012: 32013: 12014: 42015: 22017: 22018: 62019: 12020: 12021: 12022: 22023: 22024: 242025: 12026 (partial year): 2
2007high 24 (2024) · low 0 (2016)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DQK

433in 2025

2007: 182008: 342009: 402010: 492011: 552012: 1292013: 1802014: 1152015: 1312016: 3402017: 2522018: 2612019: 2182020: 2152021: 3512022: 3192023: 3402024: 5572025: 433
2007high 557 (2024) · low 18 (2007)2025

MAUDE reports naming product code DQK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071383418
2008470134
20091293240
2010964349
20111269255
20127743129
201313681180
20149904115
201571252131
2016151900340
201771462252
2018141506261
2019151131218
2020161231215
2021161321351
2022191362319
2023211332340
20241310024557
202522951433
2026231512—

What is it indicated for?

The ECG Holter evaluation software, MT-200, is an analysis software used for the analysis and evaluation of Holter ECG recordings. The Holter recordings are used for. the diagnostics of symptomatic and asymptomatic arrhythmias, i.e. bradycardia, tachycardia, diagnostic of arrhythmias in patients with coronary artery disease, in patients after reanimation, in patients with different diseases such as cardiomyopathy, high blood pressure, long QT syndrome. A…

Read the full statement (111 words)

The ECG Holter evaluation software, MT-200, is an analysis software

used for the analysis and evaluation of Holter ECG recordings. The

Holter recordings are used for. the diagnostics of symptomatic and

asymptomatic arrhythmias, i.e. bradycardia, tachycardia, diagnostic

of arrhythmias in patients with coronary artery disease, in patients

after reanimation, in patients with different diseases such as

cardiomyopathy, high blood pressure, long QT syndrome.

A Holter ECG.recording is also used for clarifying palpitations or

syncopes and attacks of dizziness or for controlling medical therapies,

or after operative treatments such as bypass .operations or PTCA. The ST

segment analysis of a Holter ECG is used for the detection of symptomatic

or asymptomatic ischemias.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973751: MT-200.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K973751

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026